Synthesis and opioid binding activity of dermorphin analogues containing cyclic β-amino acids

• Published in: Neuropeptides (Edinburgh) 1997-08, Vol.31 (4), p.367-372
• Main Authors: Bozue, B, Fueloep, F, Toth, G K, Toth, G, Szuecs, M
• Format: Article
• Language: English
• Subjects: Amino Acids, Cyclic - chemical synthesis; Amino Acids, Cyclic - metabolism; Animals; Biological and medical sciences; Brain - metabolism; Cell receptors; Cell structures and functions; Cyclohexanecarboxylic Acids - chemical synthesis; Cyclohexanecarboxylic Acids - metabolism; Fundamental and applied biological sciences. Psychology; Mass Spectrometry; Membranes - metabolism; Molecular and cellular biology; Neuropeptide receptors; Oligopeptides - chemistry; Oligopeptides - metabolism; Opioid Peptides - chemical synthesis; Opioid Peptides - chemistry; Opioid Peptides - metabolism; Protein Binding; Protein Conformation; Rats; Rats, Wistar; Stereoisomerism
• ISSN: 0143-4179; 1532-2785
• DOI: 10.1016/S0143-4179(97)90073-1

In the present work, eight conformationally constrained analogues of the μ specific opioid peptide dermorphin were synthesized by replacing D-Ala 2 with stereoisomers of β-amino-cycloalkane or cycloalkene carboxylic acids. The resulting peptides were tested for their potency to μ and δ opioid binding sites of rat brain membranes labelled with [ 3H]Tyr 1-D-Ala 2-MePhe 4-Gly-ol, [ 3H]DAMGO and [ 3H]lle 5,6deltorphin, respectively. All of the new derivatives displayed highly attenuated binding to both receptor types, albeit the decrease in their potency seemed to be less in the case of δ binding. Trans position of the β-amino groups resulted in higher binding affinities than that of the corresponding cis isomers, the latter being more flexible than the former. It is concluded that conformational constraints caused either by a rigid ring structure or cis isomers instead of D-Ala 2 in dermorphin-derived peptides are unfavourable for binding activity to either opioid receptors. We propose that interaction of the larger heptapeptide derivatives of dermorphins with the μ receptor is distinct from that of the tetrapeptide morphiceptin.